BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2996122)

  • 21. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
    Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
    J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: an analysis of 208 cases.
    Sexton C; Buss D; Powell B; O'Connor M; Rainer R; Woodruff R; Cruz J; Pettenati M; Rao PN; Case LD
    Leuk Res; 1996 Jun; 20(6):467-72. PubMed ID: 8709618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
    San Miguel JF; Gonzalez M; Cañizo MC; Anta JP; Zola H; Lopez Borrasca A
    Br J Haematol; 1986 Nov; 64(3):547-60. PubMed ID: 3466644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
    Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
    Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
    Al Safadi L; Köhler G; Schaefer HE
    Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactoferrin-deficient neutrophil polymorphonuclear leucocytes in leukaemias: a semiquantitative and ultrastructural cytochemical study.
    Miyauchi J; Watanabe Y; Enomoto Y; Takeuchi K
    J Clin Pathol; 1983 Dec; 36(12):1397-405. PubMed ID: 6317719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia.
    Nguyen PL; Olszak I; Harris NL; Preffer FI
    Am J Clin Pathol; 1998 Aug; 110(2):163-9. PubMed ID: 9704614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased degranulation of human myeloperoxidase-deficient polymorphonuclear leucocytes.
    Dri P; Cramer R; Menegazzi R; Patriarca P
    Br J Haematol; 1985 Jan; 59(1):115-25. PubMed ID: 2982389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloperoxidase gene expression in acute leukemias.
    Morishita Y; Yano K
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1459-62. PubMed ID: 2560887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural cytochemistry of leukaemic cells: characterization of the early small granules of monoblasts.
    O'Brien M; Catovsky D; Costello C
    Br J Haematol; 1980 Jun; 45(2):201-8. PubMed ID: 6254558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphological classification of acute myeloid leukemias using the FAB system. Retrospective analysis of 106 cases].
    Reiffers J; Dachary D; Bernard P; Veyret V; Boisseau MR; Broustet A
    Nouv Rev Fr Hematol (1978); 1982; 24(4):237-40. PubMed ID: 6959074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukaemia cases in Central Hospital, Riyadh (Saudi Arabia).
    Khan MQ; Shivarudrappa AS; el-Bialy S; al-Khawagi MZ; al-Mofarreh M
    J Indian Med Assoc; 1991 Feb; 89(2):38-42. PubMed ID: 2056174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A classification of acute leukaemia for the 1990s.
    Catovsky D; Matutes E; Buccheri V; Shetty V; Hanslip J; Yoshida N; Morilla R
    Ann Hematol; 1991 Feb; 62(1):16-21. PubMed ID: 2031964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial myeloperoxidase deficiency in a case of preleukaemia. II. Defects of degranulation and abnormal bactericidal activity of blood neutrophils.
    Breton-Gorius J; Houssay D; Vilde JL; Dreyfus B
    Br J Haematol; 1975 Jul; 30(3):279-88. PubMed ID: 172112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility of the French-American-British classification of acute leukemia: the Southwest Oncology Group Experience.
    Head DR; Savage RA; Cerezo L; Craven CM; Bickers JN; Hartsock R; Hosty TA; Saiki JH; Wilson HE; Morrison FS
    Am J Hematol; 1985 Jan; 18(1):47-57. PubMed ID: 2981467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.